BACKGROUND: Understanding hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is essential for HCV elimination. We aimed to differentiate reinfections from treatment failures and to identify transmission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT). METHODS: We analyzed baseline and follow-up specimens from 150 PWID from 3 OAT clinics in the Bronx, New York. Next-generation sequencing data from the hypervariable region 1 of HCV were analyzed using Global Hepatitis Outbreak and Surveillance Technology. RESULTS: There were 3 transmission linkages between study participants. Sustained virologic response (SVR) was not achieved in 9 participants: 7 had follow-up specimens with similar sequences to baseline, and 2 died. In 4 additional participants, SVR was achieved but the participants were viremic at later follow-up: 2 were reinfected with different strains, 1 had a late treatment failure, and 1 was transiently viremic 17 months after treatment. All transmission linkages were from the same OAT clinic and involved spousal or common-law partnerships. CONCLUSION: This study highlights the use of next-generation sequencing as an important tool for identifying viral transmission and to help distinguish relapse and reinfection among PWID. Results reinforce the need for harm reduction interventions among couples and those who report ongoing risk factors after SVR.
BACKGROUND: Understanding hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is essential for HCV elimination. We aimed to differentiate reinfections from treatment failures and to identify transmission linkages and associated factors in a cohort of PWID receiving opioid agonist therapy (OAT). METHODS: We analyzed baseline and follow-up specimens from 150 PWID from 3 OAT clinics in the Bronx, New York. Next-generation sequencing data from the hypervariable region 1 of HCV were analyzed using Global Hepatitis Outbreak and Surveillance Technology. RESULTS: There were 3 transmission linkages between study participants. Sustained virologic response (SVR) was not achieved in 9 participants: 7 had follow-up specimens with similar sequences to baseline, and 2 died. In 4 additional participants, SVR was achieved but the participants were viremic at later follow-up: 2 were reinfected with different strains, 1 had a late treatment failure, and 1 was transiently viremic 17 months after treatment. All transmission linkages were from the same OAT clinic and involved spousal or common-law partnerships. CONCLUSION: This study highlights the use of next-generation sequencing as an important tool for identifying viral transmission and to help distinguish relapse and reinfection among PWID. Results reinforce the need for harm reduction interventions among couples and those who report ongoing risk factors after SVR.
Authors: Matthew J Akiyama; Brianna L Norton; Julia H Arnsten; Linda Agyemang; Moonseong Heo; Alain H Litwin Journal: Ann Intern Med Date: 2019-04-09 Impact factor: 25.391
Authors: M Martinello; J Grebely; K Petoumenos; E Gane; M Hellard; D Shaw; J Sasadeusz; T L Applegate; G J Dore; G V Matthews Journal: J Viral Hepat Date: 2017-01-23 Impact factor: 3.728
Authors: Christoph Sarrazin; Vasily Isakov; Evguenia S Svarovskaia; Charlotte Hedskog; Ross Martin; Krishna Chodavarapu; Diana M Brainard; Michael D Miller; Hongmei Mo; Jean-Michel Molina; Mark S Sulkowski Journal: Clin Infect Dis Date: 2016-10-12 Impact factor: 9.079
Authors: Richard Pilon; Lynne Leonard; John Kim; Dominic Vallee; Emily De Rubeis; Ann M Jolly; John Wylie; Linda Pelude; Paul Sandstrom Journal: PLoS One Date: 2011-07-20 Impact factor: 3.240
Authors: David S Campo; Zoya Dimitrova; Lilian Yamasaki; Pavel Skums; Daryl Ty Lau; Gilberto Vaughan; Joseph C Forbi; Chong-Gee Teo; Yury Khudyakov Journal: BMC Genomics Date: 2014-07-14 Impact factor: 3.969
Authors: Noor Taweh; Esther Schlossberg; Cynthia Frank; Ank Nijhawan; Irene Kuo; Kevin Knight; Sandra A Springer Journal: Int J Drug Policy Date: 2021-05-18
Authors: Matthew J Akiyama; Lindsey Riback; Jacqueline D Reeves; Yolanda S Lie; Linda Agyemang; Brianna L Norton; Julia H Arnsten; Alain H Litwin Journal: Open Forum Infect Dis Date: 2021-09-30 Impact factor: 3.835
Authors: Claudia Minosse; Cesare E M Gruber; Martina Rueca; Chiara Taibi; Mauro Zaccarelli; Elisabetta Grilli; Marzia Montalbano; Maria R Capobianchi; Andrea Antinori; Gianpiero D'Offizi; Fiona McPhee; Anna Rosa Garbuglia Journal: Viruses Date: 2021-06-16 Impact factor: 5.048